Rust S, Funke H, Assmann G
Institut für Arterioskleroseforschung, Münster, Germany.
Nucleic Acids Res. 1993 Aug 11;21(16):3623-9. doi: 10.1093/nar/21.16.3623.
With increasing knowledge about the causal role of genetic defects in clinical diseases the necessity is apparent to have procedures for rapid diagnosis of point mutations. We developed a PCR-based technique, whereby both normal and mutant alleles can be amplified in the same reaction tube, using different length allele-specific primers. Furthermore the allele-specific primers introduce additional deliberate differences into the allelic PCR-products that drastically reduce crossreactions in subsequent cycles. This mutagenesis separates the amplification reactions of the alleles performed in the same tube. Subsequent identification of the PCR-products is done by gel electrophoresis and shows at least one of the two allelic products. Therefore, in addition to simple handling, MS-PCR provides a within-assay quality control for the exclusion of false negative results. The feasibility of this technique has been tested using six different mutations. The high sensitivity of MS-PCR also allows screening for mutation carriers in pooled DNA samples.
随着对基因缺陷在临床疾病中因果作用的认识不断增加,显然需要有快速诊断点突变的方法。我们开发了一种基于聚合酶链反应(PCR)的技术,通过该技术,正常和突变等位基因可以在同一反应管中使用不同长度的等位基因特异性引物进行扩增。此外,等位基因特异性引物会在等位基因PCR产物中引入额外的有意差异,这会在后续循环中大幅减少交叉反应。这种诱变作用将在同一管中进行的等位基因扩增反应区分开来。PCR产物的后续鉴定通过凝胶电泳完成,并且会显示出两种等位基因产物中的至少一种。因此,除了操作简单之外,多重荧光定量PCR(MS-PCR)还提供了一种用于排除假阴性结果的实验内质量控制。该技术的可行性已通过六种不同的突变进行了测试。MS-PCR的高灵敏度还允许在混合DNA样本中筛查突变携带者。